NextCure (NXTC) Gains from Sales and Divestitures (2023 - 2024)
NextCure (NXTC) posted Gains from Sales and Divestitures of -$150,000 for Q1 2024, compared with -$150,000 a year earlier.
Powered by 
Analysis
NextCure (NXTC) Gains from Sales and Divestitures (2023 - 2024) Analysis & Trends
For FY2022, NextCure's Gains from Sales and Divestitures came in at -$87,000.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | NextCure | 26.02 Mn | -94.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -150,000.00 |
| Mar 31, 2023 | -150,000.00 |
API Access
NextCure Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=NXTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "NXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=NXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();